Patients achieved a disease control rate of 97.3%
News
Lilly launches first of its kind trial for RET fusion-positive NSCLC
Selpercatinib was designed to inhibit native RET signaling as well as anticipated acquired resistance mechanisms
Health officials urge public to get flu jabs
Public Health England and NHS England warn flu can be serious and fatal in at-risk groups
Kite files second CAR-T therapy with US regulators
A submission in the EU is expected early next year
Raleigh confirmed as host city for CROY 2020
PharmaTimes are excited to announce that Raleigh, North Carolina has been confirmed as the host city for the 2020 Clinical Researcher of the Year – The Americas competition.
Bird flu outbreak confirmed in Suffolk
Officials have confirmed an outbreak of bird flu in Suffolk, but stress the risk to the public is low
More good news for Janssen’s Darzalex
The drug has hit survival and disease progression targets in Phase III trials
EU expands scope of Vertex’ Kalydeco
Children with cystic fibrosis as young as six months with certain mutations can now access the treatment
EXCLUSIVE: Brits back sharing DNA for research
The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain
Private clinic launches UK’s first MRIdian radiotherapy machine
NHS patients will be able to access the treatment via clinical trials
SMC green light for rare blood cancer treatment
NHS funding was backed for four medicines
RCEM’s winter data reveals much worse picture of A&E waits
“We are clearly in the worst state we’ve ever been in as we enter the true winter season”, says College president Dr Katherine Henderson.
Healx, Boehringer link for rare neurological disease therapy
The project will utilise Healx’ AI-based drug discovery platform
Sanofi bulks up cancer offering with Synthorx buy
The French drugmaker is spending around $2.5 billion on the deal
AZ’ Calquence boosts PFS in CLL patients
The drug demonstrates “remarkable efficacy”, says AZ’ José Baselga
